For the double localization of sst1 and
sst2 receptors with TH, somatostatin, GAD,
protein kinase C (PKC), calbindin D, or vimentin sections were
incubated overnight at 4°C with anti-sst1 antiserum at 1:10,000 or with anti-sst2 antiserum
at 1:5000, together with mouse monoclonal TH antibody in a 1:250
dilution (d108460; Incstar, Stillwater, MN), or sheep somatostatin
antibody diluted 1:1000 (13-2366; American Research Products, Belmont,
MA), or mouse monoclonal GAD antibody at 0.5 μg/ml (4670-6559;
Biogenesis, Poole, UK), or mouse monoclonal PKC antibody in a 1:10
dilution (RPN536; Amersham Research Products, Little Chalfont, UK), or
mouse monoclonal calbindin D antibody in a 1:200 dilution (C8666;
Sigma, St. Louis, MO), or mouse monoclonal vimentin antibody in a 1:200
dilution (MS-129; NeoMarkers, Union City, CA). The sections were then
washed three times in PBS containing 0.1% Triton X-100, followed by
incubation with biotinylated swine anti-rabbit antibodies 1:500 for 1
hour, blocking buffer for 20 minutes, HRP-streptABC for 45 minutes, and
biotinylated tyramide 1:50 for 8 minutes. The sections were washed
three times after each incubation period. The sections were then
incubated with streptavidin fluorescein at 1:50 (RPN1232; Amersham
Research Products) or Cy2-labeled streptavidin at 1:400 (PA42001;
Amersham Research Products) together with Texas red–conjugated donkey
anti-mouse IgG (715-075-150; Jackson ImmunoResearch, West Grove, PA) at
1:100 for visualization of TH, GAD, PKC, calbindin, and vimentin or
with Texas red–conjugated donkey anti-sheep IgG (713-076-147; Jackson
ImmunoResearch) at 1:100 for visualization of somatostatin. For
double visualization of sst2 immunoreactivity and
cone photoreceptors, sections processed for sst2 were finally subjected to streptavidin Texas red at 1:50 (RPN1233;
Amersham Research Products) together with fluorescein-labeled peanut
agglutinin (PNA) at 100 μg/ml (343249; Calbiochem, La Jolla, CA).
The sections were mounted with fluorescent mounting medium (Dako) and
examined by microscope (Axiophot; Carl Zeiss, Oberkochen, Germany)
equipped with an epifluorescence system and interference filters.
Identical fields of sections were photographed for the two fluorescent
markers.
To eliminate the possibility of cross-reaction between primary and
secondary antibodies in double-labeling studies, control sections were
made by omitting either of the primary antibodies.